News

Cell TherapiesR&D project spotlight: A collaborative approach to developing a universal ddPCR™ assay to detect residual pluripotent stem cells in cell therapy products
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
February newsletterFebruary newsletterCGT Catapult holds inaugural Seminar SeriesCGT Catapult holds inaugural Seminar SeriesRegulatory news - February 2018Regulatory news - February 2018Press Release: Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative MedicinePress Release: Cell and Gene Therapy Catapult enters into partnership with the Japanese Society for Regenerative MedicineRegulatory news - January 2018Regulatory news - January 2018January newsletterJanuary newsletterRexgenero secures Innovate UK grantRexgenero secures Innovate UK grantPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress release: CGT Catapult announces viral vector manufacturing technology collaboration with Freeline TherapeuticsPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyPress Release: CGT Catapult and CombiGene sign agreement to develop manufacturing process for novel gene therapy to treat epilepsyGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityGMP cell and gene therapy manufacturing in the UK: facilities, capabilities and capacityPress release: CGT Catapult announces vector production agreement with AdaptimmunePress release: CGT Catapult announces vector production agreement with AdaptimmuneCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of WellnessCEO Keith Thompson speaks to reporter Katy Haswell for the NHS Alliance programme – In Search of Wellness